Cargando…
FRI154 Saline Suppression Testing And Acute Hypocalcemia: Impacts On Diagnostic Testing For Primary Aldosteronism
Disclosure: W.W. Parksook: None. J.M. Brown: Consulting Fee; Self; Bayer, Inc. J. Milks: None. A. Moore: None. Y. Niebuhr: None. B. Honzel: None. A. Vaidya: Consulting Fee; Self; HRA Pharmaceuticals, Mineralys. Background: Calcium ion signaling is a critical factor required for the physiologic produ...
Autores principales: | Warachit Parksook, Wasita, Michelle Brown, Jenifer, Milks, Julia, Moore, Anna, Niebuhr, Yvonne, Honzel, Brooke, Vaidya, Anand |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554713/ http://dx.doi.org/10.1210/jendso/bvad114.666 |
Ejemplares similares
-
FRI142 The Pathophysiologic Spectrum Of Primary Aldosteronism Determined Via Saline Suppression Testing In Overweight Hypertensive And Pre-hypertensive People
por: Warachit Parksook, Wasita, et al.
Publicado: (2023) -
FRI147 A Direct-To-Patient Primary Aldosteronism Screening Program In The United States: Implementing Guidelines Nationwide
por: Michelle Brown, Jenifer, et al.
Publicado: (2023) -
Desmopressin Stimulation Test in a Pregnant Patient with Cushing's Disease
por: Parksook, Wasita Warachit, et al.
Publicado: (2021) -
OR20-3 Characterization of the Pathophysiologic Spectrum of Subclinical Primary Aldosteronism in Normotension
por: Auchus, Richard J, et al.
Publicado: (2022) -
PSUN51 Re-Calibrating Aldosterone Assay Interpretations: Immunoassay and Liquid Chromatography-Tandem Mass Spectrometry Measurements Across Multiple Controlled Physiologic Conditions
por: Brown, Jenifer M, et al.
Publicado: (2022)